Skip to main content
Erschienen in: European Journal of Orthopaedic Surgery & Traumatology 7/2019

14.05.2019 | General Review • TUMORS - METASTASES

What’s new in management of bone metastases?

verfasst von: Costantino Errani, Alberto Bazzocchi, Paolo Spinnato, Giancarlo Facchini, Laura Campanacci, Giuseppe Rossi, Andreas F. Mavrogenis

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Metastases are the most common malignancy in bone. In patients with bone metastases, especially if a limited expected survival, the indications for surgical treatment are limited, immediate pain relief and improvement in the functional status are important, and complications of treatments are unwanted. Novel medical treatments can offer an effective palliative option in these patients. Advances in interventional radiology and surgery have led to the development of less invasive techniques with the aim to achieve the same clinical results with less surgical morbidity. These include embolization, electrochemotherapy, magnetic resonance imaging-guided high-intensity focused ultrasound, and thermal ablation. Less invasive techniques combine the advantages of less invasive procedures including decreased blood loss, earlier functional recovery and initiation of adjuvant medical therapies and seem to be both effective in pain relief and local tumor control.
Literatur
6.
Zurück zum Zitat Ratasvuori M, Wedin R, Hansen BH et al (2014) Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol 110:360–365. https://doi.org/10.1002/jso.23654 CrossRefPubMed Ratasvuori M, Wedin R, Hansen BH et al (2014) Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol 110:360–365. https://​doi.​org/​10.​1002/​jso.​23654 CrossRefPubMed
21.
Zurück zum Zitat Cazzato RL, Arrigoni F, Boatta E et al (2018) Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). Radiol Med Torino 124:34–49. https://doi.org/10.1007/s11547-018-0938-8 CrossRefPubMed Cazzato RL, Arrigoni F, Boatta E et al (2018) Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). Radiol Med Torino 124:34–49. https://​doi.​org/​10.​1007/​s11547-018-0938-8 CrossRefPubMed
44.
Zurück zum Zitat Mir LM, Belehradek M, Domenge C et al (1991) Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 313:613–618PubMed Mir LM, Belehradek M, Domenge C et al (1991) Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 313:613–618PubMed
45.
Zurück zum Zitat Belehradek M, Domenge C, Luboinski B et al (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer 72:3694–3700CrossRef Belehradek M, Domenge C, Luboinski B et al (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer 72:3694–3700CrossRef
46.
Zurück zum Zitat Colombo GL, Matteo SD, Mir LM (2008) Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manag 4:541–548CrossRef Colombo GL, Matteo SD, Mir LM (2008) Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manag 4:541–548CrossRef
51.
Zurück zum Zitat Horiuchi A, Nikaido T, Mitsushita J et al (2000) Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 88:640–644CrossRef Horiuchi A, Nikaido T, Mitsushita J et al (2000) Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 88:640–644CrossRef
Metadaten
Titel
What’s new in management of bone metastases?
verfasst von
Costantino Errani
Alberto Bazzocchi
Paolo Spinnato
Giancarlo Facchini
Laura Campanacci
Giuseppe Rossi
Andreas F. Mavrogenis
Publikationsdatum
14.05.2019
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 7/2019
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-019-02446-y

Weitere Artikel der Ausgabe 7/2019

European Journal of Orthopaedic Surgery & Traumatology 7/2019 Zur Ausgabe

GENERAL REVIEW • GENERAL ORTHOPAEDICS - ARTHROPLASTY

Kuntscher’s nail removal techniques: an illustrative walk-through its journey

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.